Naslov
Burn pain managament

Autori
Lončar, Zoran ; Braš, Marijana ; Tomičić, Hrvoje

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
EBA 2005 11th European Burns Association Congress Final Programme and Abstracts / EBA Committees ; president Dr David Mackie, MD, The Netherlands - Lisabon : AJMS Portuhsl-Congressos e incentivos, Lda, 2005

Skup
11 th European Burns Association Congress

Mjesto i datum
Estoril, Portugal, 21.-24.9.05

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
burn pain; assasment; managament;
(burn pain; treatment)

Sažetak
BURN PAIN MANAGEMENT Z. Loncar, M. Bras, H. Tomicic Introduction: Burn injuries cause one of the most difficult form of pain to treat from any type of etiology. Therefore, optimal pain management is crucial to prevent the adverse consequences of uncontrolled burn pain, such as chronic pain and PTSD. Objective: The authors analysed the management of different components of burn pain in the adult patients with burn injuries. Methods: The 50 patients with burn injuries, who were hospitally treated at the Zagreb University Hospital of Traumatology, were selected as the sample for this study. Patients were interviewed within 2 weeks of their burn trauma. All patients were administered the McGill Pain Questionnaire, and the VAS was regularly used to measure current pain intensity. On the base of medical records the authors analysed their burn pain management. Results: Patients were mostly treated with continuous intravenous opiate infusions during the first days of hospitalization. After that, background pain was mostly treated with tramadol (average daily dose was 200 mg). Breakthrough pain was treated with opiate, tramadol or NSAIDs. Procedural pain was treated with intravenous application of morfine. Perioperative pain was mostly treated with intravenous application of morfine or tramadol 2-3 days after surgery. Psychotropic agents have been prescribed to all patients as adjuvant therapy for pain management as well as for the psychiatric comorbidity. Conclusion: The treatment of burn pain should be individually tailored and continuously evaluated. Tramadol has a favourable adverse-effect profile and low abuse potential, with dual mechanism of action and efficacy on neuropathic pain, and is likely to have an important role in the management of burn pain. Further research on combination analgesics regimens, as well as on adjuvant pharmacotherapy for burn pain are required.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA